Author:
Rodriguez-Torres Maribel,Lawitz Eric,Kowdley Kris V.,Nelson David R.,DeJesus Edwin,McHutchison John G.,Cornpropst Melanie T.,Mader Michael,Albanis Efsevia,Jiang Deyuan,Hebner Christy M.,Symonds William T.,Berrey Michelle M.,Lalezari Jay
Reference12 articles.
1. Chronic hepatitis C: treatments of the future;Bourlière;Clin Res Hepatol Gastroenterol,2011
2. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives;Welsch;Gut,2012
3. Direct-acting antiviral medications for chronic hepatitis C virus infection;Jazwinski;Gastroenterol Hepatol (N Y),2011
4. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American association for the study of liver diseases;Ghany;Hepatology,2011
5. The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors;McCown;Antimicrob Agents Chemother,2008
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献